Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to DEVICE/DRUG APPROVALS

Practical Neurology

HyQvia Treatment for Chronic Inflammatory Demyelinating Polyneuropathy Receives FDA Approval

Neurology January 23rd 2024

Hemophilia News Today

Approved Roctavian ‘Liberating’ for 1st US Patient Treated Outside Trials

Hematology January 22nd 2024

Medical Professionals Reference (MPR)

FDA Drug Approval Decisions Expected in February 2024

Hematology/Oncology January 22nd 2024

Oncology News Central (ONC)

FDA Approves Pembrolizumab Combination for Advanced Cervical Cancer

Hematology/Oncology January 22nd 2024

Oncology News Central (ONC)

FDA Puts Clinical Hold on Three CARsgen Therapeutics CAR-T Candidates

Hematology/Oncology January 16th 2024

Oncology News Central (ONC)

US FDA Puts Clinical Hold on Iovance’s Cancer Therapy Trial

Oncology, Medical January 8th 2024

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form